메뉴 건너뛰기




Volumn 22, Issue 5, 2007, Pages 715-719

Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy

Author keywords

CYFRA 21 1; Esophageal cancer; Radiation therapy; Recurrence; Squamous cell carcinoma antigen

Indexed keywords

CYTOKERATIN 19 FRAGMENT; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR ANTIGEN;

EID: 34247206431     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04498.x     Document Type: Article
Times cited : (24)

References (18)
  • 1
    • 0036499029 scopus 로고    scopus 로고
    • INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy
    • Minsky BD, Pajak TF, Ginsberg RJ et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J. Clin. Oncol. 2002; 20: 1167-74.
    • (2002) J. Clin. Oncol , vol.20 , pp. 1167-1174
    • Minsky, B.D.1    Pajak, T.F.2    Ginsberg, R.J.3
  • 2
    • 0842286828 scopus 로고    scopus 로고
    • Definitive chemoradiation in patients with inoperable oesophageal carcinoma
    • Crosby TD, Brewster AE, Borley A et al. Definitive chemoradiation in patients with inoperable oesophageal carcinoma. Br. J. Cancer 2004; 90: 70-5.
    • (2004) Br. J. Cancer , vol.90 , pp. 70-75
    • Crosby, T.D.1    Brewster, A.E.2    Borley, A.3
  • 3
    • 0037443481 scopus 로고    scopus 로고
    • Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: A practice guideline
    • Wong RK, Malthaner RA, Zuraw L et al. Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline. Int. J. Radiat. Oncol. Biol. Phys. 2003; 55: 930-42.
    • (2003) Int. J. Radiat. Oncol. Biol. Phys , vol.55 , pp. 930-942
    • Wong, R.K.1    Malthaner, R.A.2    Zuraw, L.3
  • 4
    • 0035863382 scopus 로고    scopus 로고
    • Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma
    • Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J. Clin. Oncol. 2001; 19: 305-13.
    • (2001) J. Clin. Oncol , vol.19 , pp. 305-313
    • Urba, S.G.1    Orringer, M.B.2    Turrisi, A.3    Iannettoni, M.4    Forastiere, A.5    Strawderman, M.6
  • 5
    • 10044285985 scopus 로고    scopus 로고
    • Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients
    • Liao Z, Zhang Z, Jin J et al. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 2004; 60: 1484-93.
    • (2004) Int. J. Radiat. Oncol. Biol. Phys , vol.60 , pp. 1484-1493
    • Liao, Z.1    Zhang, Z.2    Jin, J.3
  • 6
    • 0037434412 scopus 로고    scopus 로고
    • Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus
    • Kaneko K, Ito H, Konishi K et al. Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus. Br. J. Cancer 2003; 88: 18-24.
    • (2003) Br. J. Cancer , vol.88 , pp. 18-24
    • Kaneko, K.1    Ito, H.2    Konishi, K.3
  • 7
    • 0030910460 scopus 로고    scopus 로고
    • CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma
    • Yamamoto K, Oka M, Hayashi H, Tangoku A, Gondo T, Suzuki T. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma. Cancer 1997; 79: 1647-55.
    • (1997) Cancer , vol.79 , pp. 1647-1655
    • Yamamoto, K.1    Oka, M.2    Hayashi, H.3    Tangoku, A.4    Gondo, T.5    Suzuki, T.6
  • 8
    • 0034306852 scopus 로고    scopus 로고
    • CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: Clinical utility for detection of recurrences
    • Kawaguchi H, Ohno S, Miyazaki M et al. CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: clinical utility for detection of recurrences. Cancer 2000; 89: 1413-17.
    • (2000) Cancer , vol.89 , pp. 1413-1417
    • Kawaguchi, H.1    Ohno, S.2    Miyazaki, M.3
  • 9
    • 0037388473 scopus 로고    scopus 로고
    • Prognostic significance of CYFRA 21-1 in patients with esophageal squamous cell carcinoma
    • Shimada H, Nabeya Y, Okazumi S et al. Prognostic significance of CYFRA 21-1 in patients with esophageal squamous cell carcinoma. J. Am. Coll. Surg. 2003; 196: 573-8.
    • (2003) J. Am. Coll. Surg , vol.196 , pp. 573-578
    • Shimada, H.1    Nabeya, Y.2    Okazumi, S.3
  • 11
    • 16544372409 scopus 로고    scopus 로고
    • Detection of bone marrow micrometastasis in esophageal cancer patients by immunomagnetic separation
    • Nakamura T, Matsunami K, Hayashi K, Ota M, Ide H, Takasaki K. Detection of bone marrow micrometastasis in esophageal cancer patients by immunomagnetic separation. Oncol. Rep. 2004; 11: 999-1003.
    • (2004) Oncol. Rep , vol.11 , pp. 999-1003
    • Nakamura, T.1    Matsunami, K.2    Hayashi, K.3    Ota, M.4    Ide, H.5    Takasaki, K.6
  • 12
    • 3242725210 scopus 로고    scopus 로고
    • CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients
    • Muley T, Dienemann H, Ebert W. CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients. Anticancer Res. 2004; 24: 1953-6.
    • (2004) Anticancer Res , vol.24 , pp. 1953-1956
    • Muley, T.1    Dienemann, H.2    Ebert, W.3
  • 13
    • 3042683689 scopus 로고    scopus 로고
    • Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer
    • Holdenrieder S, Stieber P, von Pawel J et al. Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer. Clin. Cancer Res. 2004; 10: 5981-7.
    • (2004) Clin. Cancer Res , vol.10 , pp. 5981-5987
    • Holdenrieder, S.1    Stieber, P.2    von Pawel, J.3
  • 14
    • 0027279541 scopus 로고
    • CYFRA 21-1. A new marker in lung cancer
    • Stieber P, Hasholzner U, Bodenmuller H et al. CYFRA 21-1. A new marker in lung cancer. Cancer 1993; 72: 707-13.
    • (1993) Cancer , vol.72 , pp. 707-713
    • Stieber, P.1    Hasholzner, U.2    Bodenmuller, H.3
  • 16
    • 3543147149 scopus 로고    scopus 로고
    • Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy
    • Ma BB, Leungm SF, Hui EP et al. Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy. Cancer 2004; 101: 776-81.
    • (2004) Cancer , vol.101 , pp. 776-781
    • Ma, B.B.1    Leungm, S.F.2    Hui, E.P.3
  • 17
    • 4644325834 scopus 로고    scopus 로고
    • Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer
    • Nakata B, Takashima T, Ogawa Y, Ishikawa T, Hirakawa K. Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer. Br. J. Cancer 2004; 91: 873-8.
    • (2004) Br. J. Cancer , vol.91 , pp. 873-878
    • Nakata, B.1    Takashima, T.2    Ogawa, Y.3    Ishikawa, T.4    Hirakawa, K.5
  • 18
    • 0037714432 scopus 로고    scopus 로고
    • Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix
    • Ohno T, Nakayama Y, Nakamoto S et al. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix. Cancer 2003; 97: 3114-20.
    • (2003) Cancer , vol.97 , pp. 3114-3120
    • Ohno, T.1    Nakayama, Y.2    Nakamoto, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.